These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 37989266)

  • 21. Metabolic disorders in diabetes.
    Fraser R
    Br Med J; 1972 Dec; 4(5840):591-6. PubMed ID: 4629981
    [No Abstract]   [Full Text] [Related]  

  • 22. Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity.
    Lee MJ; Pramyothin P; Karastergiou K; Fried SK
    Biochim Biophys Acta; 2014 Mar; 1842(3):473-81. PubMed ID: 23735216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Interplay Between Tissue Niche and Macrophage Cellular Metabolism in Obesity.
    Daemen S; Schilling JD
    Front Immunol; 2019; 10():3133. PubMed ID: 32038642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease.
    Tarantino G; Finelli C
    World J Gastroenterol; 2013 Oct; 19(40):6735-43. PubMed ID: 24187449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurologic complications of endocrine diseases.
    Kaminski HJ; Ruff RL
    Neurol Clin; 1989 Aug; 7(3):489-508. PubMed ID: 2671633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor macroenvironment and metabolism.
    Al-Zoughbi W; Al-Zhoughbi W; Huang J; Paramasivan GS; Till H; Pichler M; Guertl-Lackner B; Hoefler G
    Semin Oncol; 2014 Apr; 41(2):281-95. PubMed ID: 24787299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic Syndrome in Cushing's Syndrome Patients.
    Ferraù F; Korbonits M
    Front Horm Res; 2018; 49():85-103. PubMed ID: 29894989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic comorbidities in Cushing's syndrome.
    Ferraù F; Korbonits M
    Eur J Endocrinol; 2015 Oct; 173(4):M133-57. PubMed ID: 26060052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficiency of energy metabolism in obesity.
    Gordon ES
    Am J Clin Nutr; 1968 Dec; 21(12):1480-5. PubMed ID: 5724826
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiple endocrine neoplasia type IIa associated with Cushing's syndrome.
    Borzouei S; Mousavi Bahar SH; Fereydouni MA; Salimbahrami SA; Taghipour M
    Arch Iran Med; 2014 Jun; 17(6):451-4. PubMed ID: 24916533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cushing's Syndrome Effects on the Thyroid.
    Paragliola RM; Corsello A; Papi G; Pontecorvi A; Corsello SM
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
    Stewart PM
    Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adipose tissue as an endocrine organ: role in pathogenesis of ischemic heart disease and insulin independent diabetes mellitus].
    Lapchyns'ka II; Stefaniuk MF
    Lik Sprava; 2002; (8):36-9. PubMed ID: 12669536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation among body composition and metabolic regulation in a male mouse model of Cushing's syndrome.
    Uehara M; Yamazaki H; Yoshikawa N; Kuribara-Souta A; Tanaka H
    Endocr J; 2020 Jan; 67(1):21-30. PubMed ID: 31495810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut-adipose tissue crosstalk: A bridge to novel therapeutic targets in metabolic syndrome?
    Rosendo-Silva D; Matafome P
    Obes Rev; 2021 Feb; 22(2):e13130. PubMed ID: 32815267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does central obesity reflect "Cushing's disease of the omentum"?
    Bujalska IJ; Kumar S; Stewart PM
    Lancet; 1997 Apr; 349(9060):1210-3. PubMed ID: 9130942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology of dyslipidemia in Cushing's syndrome.
    Arnaldi G; Scandali VM; Trementino L; Cardinaletti M; Appolloni G; Boscaro M
    Neuroendocrinology; 2010; 92 Suppl 1():86-90. PubMed ID: 20829625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HYDROXYPROLINE EXCRETION IN ENDOCRINE DISEASE.
    BENOIT FL; THEIL GB; WATTEN RH
    Metabolism; 1963 Dec; 12():1072-82. PubMed ID: 14100279
    [No Abstract]   [Full Text] [Related]  

  • 40. Feeding the critically ill obese patient: a systematic review protocol.
    Secombe P; Harley S; Chapman M; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.